Context sidebar

March 2026

31.03.2026

BW301_40_001d_FO Gesuche nach Art. 21, Abs. 1, Bst. c, HMG (DOCX, 361 kB, 17.03.2026)

BW630_40_810e_PU swissdamed Machine-to-Machine REST API_DocumentationAPI_Documentation (PDF, 1 MB, 31.03.2026)

30.03.2026

BW630_40_871e_WL swissdamed Service Agreement (PDF, 314 kB, 27.03.2026)

MU600_00_017e_MB 3D printers medical devices (PDF, 317 kB, 26.03.2026)

26.03.2026

BW301_10_003d_FO No-Objection Certificate (DOCX, 361 kB, 01.03.2026)

BW600_00_015e_MB Clinical investigations with medical devices (PDF, 713 kB, 25.03.2026)

MU680_20_009e_WL Incident economic operators (PDF, 343 kB, 26.03.2026)

MU680_21_010e_WL FSCA economic operators (PDF, 300 kB, 26.03.2026)

25.03.2026

SI300_00_001d_WL Datenschutzerklärung (PDF, 192 kB, 22.10.2025)

24.03.2026

BW617_00_003e_MB Derogation MEP (PDF, 263 kB, 20.03.2026)

MU600_00_006e_MB Procurement of medical devices in health institutions (PDF, 486 kB, 20.03.2026)

MU600_00_007e_MB Products without an intended medical purpose (PDF, 741 kB, 20.03.2026)

MU600_00_016e_MB Obligations Economic Operators CH (PDF, 1 MB, 20.03.2026)

MU600_00_018e_MB Systems and procedure packs (PDF, 339 kB, 23.03.2026)

ZL300_00_003e_FO Form Variations and extensions HAM (DOCX, 818 kB, 24.03.2026)valid from 1 February 2026

17.03.2026

BW102_50_001e_WL Guidance document Controlled Substances Company Meetings (PDF, 240 kB, 06.03.2026)

BW102_50_008e_FO Application Controlled Substances Company Meeting (DOCX, 372 kB, 06.03.2026)

BW102_50_009e_FO Controlled Substances Company Meeting Minutes (DOCX, 363 kB, 06.03.2026)

MU101_10_796e_FO Signal Notification Form (DOCX, 371 kB, 15.03.2026)

RN106_00_002d_MB Anforderungen PhHelv Präparate (PDF, 364 kB, 18.02.2026)

04.03.2026

BW610_10_029e_FO Application for fee reduction (PDF, 1 MB, 04.03.2026)

02.03.2026

BW630_40_001e_PU swissdamed UDI Data Dictionary (XLSX, 126 kB, 23.02.2026)

OS000_00_003e_MB Archive access (PDF, 199 kB, 02.03.2026)

01.03.2026

MU102_10_001e_FO Quality defect report (DOCX, 372 kB, 01.03.2026)

MU105_00_002d_MB Botulinumtoxin - Leitlinien (PDF, 250 kB, 01.03.2026)

ZL000_00_019e_WL Guidance document Authorisation human medicinal product under Art. 13 TPA (PDF, 444 kB, 01.03.2026)

ZL000_00_020e_WL Guidance document Formal requirements (PDF, 995 kB, 01.03.2026)

ZL000_00_027e_WL Guidance document Product information for human medicinal products (PDF, 939 kB, 10.03.2026)

ZL000_00_050e_WL Guidance document Mobile technologies (PDF, 266 kB, 01.03.2026)

ZL101_00_004e_FO Form Information for application Art.13 TPA (DOCX, 197 kB, 01.03.2026)

ZL106_00_888e_WL Guidance document Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import) (PDF, 400 kB, 01.03.2026)

Top of page